Elevate Your Health Journey
Find the tools and support you need to fight against Brain Cancer!
Dr. Tulika Ranjan MD, CEO
Neuro-oncology
Director Neuro-Oncology Operations at Dartmouth Hitchcock
.jpg)
15+ Years of Experience in Neuro-Oncology
Accomplished Neuro-Oncologist with over 15 years of expertise in treating brain cancers and complex neurological disorders
Completed a Fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center (New York) and earned advanced certifications in Artificial Intelligence in Healthcare from MIT and Harvard. Also holds a General Management degree from Harvard.
Skilled in neuro-oncology, brain cancer clinical research, neuroimaging, precision medicine, healthcare management, and leadership in multidisciplinary healthcare teams.
Recipient of the 8th AACR Team Science Award (Duke/NCI/Johns Hopkins, 2014) and served as Medical Director for the landmark FLAURA trial, which led to the FDA approval of Osimertinib in 2015 for lung cancer.
About Me
Dr. Ranjan completed her training in neurology at the University of Medicine and Dentistry of New Jersey (UMDNJ), now known as Rutgers School of Biomedical and Health Services, followed by a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. She was recruited to Duke University Preston Robert Tisch Brain Tumor Center in North Carolina, one of the best comprehensive neuro-oncology programs in US, where she focused on innovative clinical/translational trials, including the Polio vaccine trial (PVSRIPO).
Dr. Ranjan served as director of neuro-oncology at Allegheny Health Network, a 13-hospital medical system with facilities throughout western Pennsylvania and one hospital in western New York. In this role, she oversaw a comprehensive neuro-oncology team that specialized in advanced modalities such as laser interstitial thermal therapy (treatment of hard
Specialties
- Neuro-oncology
- Neurology
Areas of Focus
- Glioblastoma
- Benign and malignant brain tumors
- Brain metastases
- Paraneoplastic neurologic disorder
- Precision oncology
- ChemoID
- OPTUNE Gio
- Artificial Intelligence in Health Care
Education
Medical School
MBBS, Sri Krishna Medical College, India, 2002
Residency
Neurology, University of Medicine and Dentistry (UMDNJ), Rutgers, 2008
Fellowship
Neuro-oncology, Memorial Sloan Kettering Cancer Center (MSKCC), 2009
Executive Education
Harvard Business School General Management Program, Boston, Massachusetts, 2021
Certifications
- Artificial Intelligence in Health Care, MIT Sloan Boston, Massachusetts, 01/2024
- AI for Health Care: Concepts and Applications, Harvard TH Chan PH, Boston, Massachusetts, 02/2024
- HMX - Harvard Medical School Immuno-Oncology Certification, 08/2024
Membership
- Chairperson Circle, Harvard Business School
- D3 AI Group, Harvard Business School
- SNO (Society of Neuro-Oncology)
TREATMENTS OFFERED
Woman with terminal brain tumor helps others
An inspiring story of resilience and compassion, where one woman turns her own diagnosis into a mission to help others facing similar battles.
About Brain Cancer Innovation
Our Philosophy
Om.Ai aims to be at the forefront of AI-driven brain cancer research, leveraging cutting-edge technology to unlock new insights and improve clinical research and patient outcomes. By combining advanced analytics with collaboration, we aim to pioneer innovative solutions poised to contribute to the fight against brain cancer, significantly advancing the field of oncology care.
Our Expertise
Om.Ai stands out as a pioneering non-profit organization dedicated to combating brain cancer through the innovative application of artificial intelligence (AI). At the heart of Om.Ai's mission is the belief that advanced technologies can lead to breakthroughs in understanding, diagnosing, and treating one of the most challenging medical conditions. The organization's expertise spans several key areas, each contributing to its overarching goal of revolutionizing brain cancer care.